to women through therapeutic donor insemination (TDI) has Arnaud de Villeneuve, 34295 Montpellier Cedex 5 and 4 Department been reported (Steward et al., 1985; Nagel et al., 1986; Berry of Virology, Hôpital Saint-Eloi, 34295 Montpellier Cedex 5, France et al., 1987) . The risk of CMV transmission through TDI has 5 To whom correspondence should be addressed also been established (Prior et al., 1994) . Therefore, the American Fertility Society (1993) recommended the determinaThe presence of cytomegalovirus (CMV) in semen was tion of CMV serological status of semen donors by a CMVretrospectively evaluated in 178 cryopreserved semen specific immunoglobulin G (IgG) assay and stated that semen samples obtained from 97 donors recruited by two sperm from CMV-seropositive donors may only be used to inseminate banks. Thirty-three (34.0%) donors were CMV-seroneg-CMV-seropositive recipients. The French legislation is more ative, 51 (52.6%) were CMV-seropositive and 13 (13.4%) restrictive, since only semen specimens from CMV-seroneghad an unknown serological status. CMV was detected in ative donors can be used for TDI; these specimens must be sperm specimens by cell culture and polymerase chain cryopreserved and quarantined for at least 180 days before reaction (PCR). CMV was detected in five (2.8%) samples use. On this basis, specimens from~50% of French volunteer from two (2.0%) donors by cell culture and in 10 samples donors are rejected. (5.6%) from five donors (5.1%) by PCR; all the samples To date, the frequency of CMV secretion into semen which were positive by cell culture were also positive specimens obtained from healthy volunteer donors has not been by PCR. Our data indicate that cryopreserved semen evaluated. Therefore, we wondered whether direct detection of specimens obtained from healthy volunteer donors repres-CMV in semen could constitute a more informative marker of ent a potential source of CMV infection through therapeutic semen infectivity than the CMV-antibody status. This study donor insemination. PCR, which is more sensitive than cell was thus designed to establish the frequency of CMV infection culture, should be used for direct and rapid identification in semen collected from healthy volunteer donors recruited by of CMV in semen samples collected from volunteer donors.
our sperm banks in two French university hospitals.
Introduction
aged from 25 to 48 years, they lived in stable couples and had previously fathered at least one child. One semen donation was
were not cryopreserved and thus were not included in this study. amplification, tubes were pre-heated for 5 min at 94°C and subjected to 30 cycles of denaturation at 94°C for 1 min, primer annealing at Ejaculates were aliquotted into 0.25 ml straws and cryopreserved in liquid nitrogen according to a previously described procedure 55°C for 1 min, and extension at 72°C for 1 min; the extension was 7 min in the last cycle. After the first amplification with outer primers, (Behrmann and Ackerman, 1969) which does not affect CMV viability. Transport to the laboratory and conservation until testing were carried 5 µl of the amplification product was amplified under the same conditions by using the inner primers. The PCR products were out in liquid nitrogen.
electrophoresed on a 2% agarose gel containing ethidium bromide CMV antibody tests and the gel was photographed with short wave ultraviolet illumination. Both PCR procedures were performed under stringent conditions Sera were collected at the time of the ejaculate collection. They were (Kwok and Higuchi, 1989 ). All specimens were tested at least twice screened for the presence of anti-CMV IgG [IMX CMV IgG; Abbott, in separate runs; positive, negative and blank controls were included Rungis, Toulouse, France (Toulouse) or Vidas CMV IgG; Biomérieux, in each run. DNA extracted from CMV-infected or mock-infected Marcy l'Etoile, France (Montpellier)] and IgM [Wellcozyme anti-MRC5 cells were used as positive and negative controls respectively; CMV IgM; Wellcome Diagnostics, Paris, France (Toulouse) or Captia distilled water was used as blank control. Samples from the patients CMV-M; Malvern, PA, USA (Montpellier)].
who had CMV detected in semen were exchanged between the two centres in order to be tested by each PCR procedure. In addition, 28 Detection of CMV by cell culture randomly selected samples (14 from each centre) were also exchanged Semen samples were tested for the presence of CMV by shell vial and tested by each procedure. In our experience, the limit of detection culture (SVC) in both centres and additionally, by conventional cell of both PCR procedures was Ͻ10 CMV DNA copies/ml. culture (CCC) in Toulouse. SVC was performed on MRC-5 monolayer cell cultures in 24-well tissue culture plates. A randomly selected aliquot from each ejaculate was diluted 1:10 and 1:100 in Eagle's
Results

minimum essential medium (MEM) supplemented with 2% fetal calf
The donors included in this study had a sperm count (mean serum (FCS) and dilutions were inoculated onto cells. The aim of the sample dilutions was to suppress the potential toxicity of semen.
Ϯ SD) of 89.6 Ϯ 76.5ϫ10 6 /ml, the progressive motility was
Plates were then centrifuged at 980 g for 45 min at 37°C. After 51.4 Ϯ 8.3% and the normal morphology was 58.8 Ϯ 12.0%.
removal of the inoculum and addition of 2 ml of MEM-2% FCS, All the donors were clinically healthy. They were free of plates were incubated for 18 h at 37°C in 5% CO 2 . Identification of sexually transmitted or heritable diseases and they were CMV-immediate-early antigen was performed by an immunoperoxidseronegative for HIV, HTLV, HBC, HCV and T. pallidum. ase procedure, using monoclonal antibody E-13 (Argène, Varilhes, Thirty-three donors (34.0%) were CMV-seronegative, 51
France) directed against the products of the major immediate-early (52.6%) were CMV-seropositive and the remaining 13 donors gene (Mazeron et al., 1992) , antimouse immunoglobulin G peroxidase- were obtained from the donors who had unknown serological For CCC, semen samples diluted 1:10 were inoculated onto MRC-5 cell monolayers as described above. Cells were examined for status. All the donors tested were negative for CMV-specific CMV-specific cytopathic effects (CPE) twice a week. Cultures were IgM antibodies. maintained for 6 weeks before being considered as negative. The
As shown in Table I , CMV was detected in five (2.8%) AD169 CMV-strain was used as a positive control.
ejaculates from two (2.1%) donors by cell culture and in 10 (5.6%) ejaculates from five (5.1%) donors by PCR. Among Detection of CMV DNA by PCR the CMV-seropositive donors, four (7.8%) showed CMV A randomly selected aliquot from each ejaculate was tested by PCR.
shedding in semen and CMV was detected in five (4.5%) Each centre used its own 'in house' PCR procedure. In Toulouse, and nine (8.1%) of the samples collected from the CMV-200 µl of semen was inoculated in lysis buffer (10 mM Tris-HCl pH seropositive donors by cell culture and PCR respectively. 8.2, 50 mM KCl, 2.5 mM MgCl 2 , 0.45% Nonidet P40, 0.45% Tween Three of the donors were found positive for CMV seminal 20 and 60 µg/ml proteinase K) for 2 h at 36°C. Total DNA was shedding by both PCR procedures, whereas two samples from extracted according to standard procedures (Maniatis et al., 1982) . one donor were found positive only in Toulouse and one sample PCR was performed according to previously published conditions (Hsia et al., 1989) by using primers located in the highly conserved from another donor was found positive only in Montpellier. All immediate-early gene region 1 (IE1). The PCR product was detected the ejaculates which were positive by cell culture were also by a commercial enzyme immunoassay, according to the manufacpositive by PCR in both centres. Concordant negative results turer's instructions (Gen-Eti-K; Sorin Biomedica, Anthony, France).
were obtained by both PCR procedures in the 28 semen In Montpellier, semen samples were incubated for 1 h at 56°C in samples exchanged between both centres. lysis buffer. Lysates were then heated for 10 min at 95°C to inactivate proteinase K. After centrifugation (10 min at 10 000 r.p.m.), 10 µl of supernatant was directly used for DNA amplification in a 50 µl Discussion reaction mixture. Nested PCR was performed by using outer and Microorganisms are often detected in ejaculates of asymptominner primer sets located in the IE1 region, delimiting a 242 bp atic individuals, which could influence in-vitro fertilization sequence and a 148 bp sequence, respectively (Brytting et al., 1992) .
success (Shalika et al., 1996) . Moreover, CMV shedding in The final concentration of each deoxyribonucleotide triphosphate and semen has been previously reported in studies conducted in each primer was 200 µM and 0.2 µM, respectively. Each tube HIV-infected patients (Rinaldo et al., 1992; Krieger et al., (Handsfield et al., 1985) . CMV seminal shedding has also positive controls for each run, the possibility of false-positive results is unlikely. Moreover, concordant negative results been investigated in men seeking fertility evaluation and controversial results have been reported. Indeed, Bantel-Shaal obtained in the 28 randomly selected specimens exchanged between the two centres indicated that both PCR procedures et al. (1993) concluded that CMV was not present in the semen from 63 men tested in Germany, whereas in Taiwan, have a good specificity. Therefore the discrepant results are probably due to very low levels of CMV DNA in the semen Shen et al. (1994) and Yang et al. (1995) found a high prevalence (32.7 and 33.5% respectively) of CMV shedding specimens examined. Indeed, if the level of DNA is around the detection limit, its detection by PCR is linked to the chance in semen. This discrepancy might be explained by marked differences in CMV seroprevalence and by the different of obtaining sufficient numbers of DNA copies in the volume of semen sampled for analysis. Moreover, each PCR procedure procedures used for CMV detection (DNA hybridization and PCR respectively). To our knowledge, studies on CMV seminal was performed on different ejaculate aliquots and this difference also could explain the discrepancies observed. These shedding in healthy semen donors have not been reported until now. Such a study could be of interest, since CMV in semen discrepancies could also result from different sensitivities of the two PCR procedures to inhibitors present in the semen represents a source of infection for women undergoing a TDI and could be a cause of congenital CMV disease in their specimens. Unlike cell culture, which detects only infectious virions, offspring. Therefore, we conducted a retrospective study on cryopreserved semen samples collected from healthy volunteer the PCR procedure only detects viral DNA and thus cannot prove the infectious character of a semen specimen. However donors in our sperm banks. Detection of infectious CMV was performed by cell culture; samples were also tested by PCR PCR is a highly sensitive technique which could constitute an effective screening method to exclude those potentially in consideration of the high sensitivity of this technique.
Our results clearly indicate that CMV is present in the infectious specimens. The detection of CMV-specific IgG antibodies in serum is indicative only of a past infection and semen from healthy volunteer donors, since CMV was detected in 5.6% of the specimens tested. Moreover, the infectious cannot substantiate CMV shedding in semen. Moreover, our results show that most CMV-seropositive donors do not excrete character of semen was assessed in 2.8% of the specimens by isolation of CMV in cell culture. Indeed CMV was detected CMV in their semen. Our results also indicate that CMVspecific IgM antibody status is not predictive of CMV shedding in 8.1% of the semen specimens collected from the CMVseropositive donors and 4.5% of these specimens were found in semen, since all the donors were negative for this marker. Since, in France, all the semen specimens collected from CMVto be infectious by cell culture. Among the five donors who had CMV in semen, three excreted CMV transiently, whereas seropositive subjects are currently excluded from donation, a systematic testing by PCR may lead to reconsideration of the the remaining two donors presented protracted CMV shedding, since CMV was detected by cell culture and PCR in consecutcriteria for donor exclusion. A CMV infection cannot be completely excluded in CMVive samples.
Among the donors who had CMV detected by PCR, discrepseronegative donors. Indeed CMV serological tests are not 100% sensitive and, moreover, it has been reported that CMV ancies between the two PCR procedures were observed in four samples. Since PCR was repeatedly performed for each sample nucleic acids can be detected in a subset of CMV-seronegative subjects (Schrier et al., 1985; Zhang et al., 1995) . Therefore, under stringent conditions, with inclusion of negative and
